Deal Watch: Japan’s JCR Inks Pacts With Sumitomo Dainippon, Alexion

Agreement with Alexion is JCR’s first international deal for its blood-brain barrier drug delivery technology. Sartoris buys PolyPlus from private equity investors.

Deal Watch 2021
• Source: Shutterstock

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.

JCR Pharmaceuticals Co., Ltd. and Sumitomo Pharma Co., Ltd. agreed on 6 April to co-promote the former’s Izcargo...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deal Watch

More from Deals